Neoadjuvant therapy of camrelizumab combined with chemotherapy in patients (pts) with resectable esophageal squamous cell cancer (ESCC): Preliminary results of a preoperative phase exploratory clinical trial

被引：0
|
作者：
Dong, Y. [1 ,2 ]
Luo, J. [3 ]
Liu, S. [4 ]
Lin, Y. [5 ]
Han, H. [5 ]
机构：
[1] Shandong First Med Univ, Shandong Canc Hosp & Inst, Thorac Surg, Jinan, Peoples R China
[2] Shandong Acad Med Sci, Jinan, Peoples R China
[3] Shandong Canc Hosp, Oncol, Jinan, Peoples R China
[4] Shandong Univ, Thorac Surg, Shandong Canc Hosp, Jinan, Peoples R China
[5] Jiangsu Hengrui Pharmaceut Co Ltd, Dept Med, Jinan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1225P
引用
收藏
页码：S1109 / S1109
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Updated data from a prospective, phase II trial
    Chen, Yueyun
    Yuan, Yong
    Yang, Yu-Shang
    Lin, Zhen
    Tian, Jiangfang
    Liu, Ting
    Yue, Zheng
    Shi, Hua-Shan
    Hu, Yang
    Ding, Zhen-Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Neoadjuvant chemotherapy combined with camrelizumab for locally advanced head and neck squamous cell carcinoma: A phase II trial
    Yang, K.
    Zhang, X.
    Zhang, Z.
    Wu, B.
    Peng, G.
    Huang, J.
    Ding, Q.
    Xiao, G.
    Ma, H.
    Yang, C.
    Xiong, X.
    Shi, L.
    Yang, J.
    Hong, X.
    Wei, J.
    Qin, Y.
    Zhong, Y.
    Zhou, Y.
    Zhao, X.
    Leng, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S1442 - S1443
  • [23] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [24] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Guozhen Yang
    Xiaodong Su
    Yuanheng Huang
    Guangyu Luo
    Zhiqiang Wang
    Peiqiang Cai
    Yating Zheng
    Ting Bei
    Mengli Huang
    Yuezong Bai
    Haoqiang He
    Jin Xiang
    Muyan Cai
    Jiudi Zhong
    Qiyu Guo
    Xu Zhang
    Journal of Translational Medicine, 21
  • [25] Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trial
    Wu, Zixiang
    Wu, Chuanqiang
    Zhao, Jing
    Wu, Cong
    Peng, Haixian
    Wang, Qi
    Bai, Rui
    Fang, Xuefeng
    He, Hong
    Shen, Hong
    Wu, Ming
    ECLINICALMEDICINE, 2024, 71
  • [26] Neoadjuvant tislelizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis of a phase 2 study
    Zhuo, Na
    Qiu, Wei
    He, Jia
    Li, Li
    Wang, Qiang
    Yu, Shuangni
    Liu, Wei
    Zhao, Lin
    Bai, Chunmei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.
    Chen, Yueyun
    Ding, Zhen-Yu
    Yuan, Yong
    Yang, Yu-Shang
    Lin, Zhen
    Tian, Jiangfang
    Liu, Ting
    Yue, Zheng
    Shi, Hua-Shan
    Hu, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 352 - 352
  • [28] Neoadjuvant sintilimab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, phase 2 trial
    Zhang, Zhi
    Ye, Jinjun
    Li, Hui
    Gu, Dayong
    Du, Mingyu
    Ai, Dashan
    Chen, Wei
    Fang, Ying
    Xu, Xinyu
    Bai, Chenguang
    Zhao, Kuaile
    Zhou, Guoren
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Neoadjuvant tislelizumab combined with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Single arm phase II study
    Jin, Peng
    Gao, Yong Sheng
    Fu, Zheng
    Yang, Wen Feng
    Meng, Xue
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Neoadjuvant PD-1 blockade combined with chemotherapy for patients with resectable locally advanced esophageal squamous cell carcinoma (ESCC): A real world data analysis
    Lv, H.
    Tian, Y.
    Huang, C.
    Sun, B.
    Gai, C.
    Li, Z.
    Tian, Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S1423 - S1423
12345